Expert consensus for diagnosis and treatment of coagulation dysfunction in COVID-19 / 解放军医学杂志
Medical Journal of Chinese People's Liberation Army
; (12): 335-344, 2020.
Article
em Zh
| WPRIM
| ID: wpr-849722
Biblioteca responsável:
WPRO
ABSTRACT
Since December 2019, a novel type of coronavirus disease (COVID-19) in Wuhan led to an outbreak throughout the world. To date, there have been more than 1,260,000 COVID-19 patients, with a mortality rate of approximately 5.44%. Studies have shown that coagulation dysfunction is a major cause of death in patients with severe COVID-19. Therefore, the People's Liberation Army Professional Committee of Critical Care Medicine and Chinese Thrombosis and Hemostasis Committee grouped experts from the frontline of the Wuhan epidemic to come together and develop an expert consensus on diagnosis and treatment of coagulation dysfunction associated with severe COVID-19 infection. This consensus includes an overview of COVID-19-related coagulation dysfunction, tests for coagulation, anticoagulation therapy, replacement therapy, supportive therapy and prevention. The consensus produced 18 recommendations which are being used to guide clinical work.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Diagnostic_studies
/
Guideline
Idioma:
Zh
Revista:
Medical Journal of Chinese People's Liberation Army
Ano de publicação:
2020
Tipo de documento:
Article